GKB Ophthalmics Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from GKB Ophthalmics Ltd. on BSE

Search Inside the pdf :

GKB Ophthalmics Ltd.

16 Jul 2025

74.89

2.56%

Company Update

GKB Ophthalmics Ltd - 533212 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Please find attached copies of Newspaper cuttings of the Notice for Annual General Meeting published in The Times of India (Goa Edition ) dated July 13, 2025 and on Pudhari (Marathi) dated July 13, 2025. Please acknowledge receipt.

pdf

GKB Ophthalmics Ltd.

10 Jul 2025

74.89

2.56%

Company Update

GKB Ophthalmics Ltd - 533212 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Please find herewith Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulation, 2018, for the quarter ended June 30, 2025. Kindly acknowledge receipt of the same.

pdf

GKB Ophthalmics Ltd.

09 Jul 2025

74.89

2.56%

Corp. Note

GKB Ophthalmics Ltd - 533212 - Board Meeting Outcome for Disclosure Under Regulation 30 SEBI (LODR) …

BSE India

Pursuant to Regulation 30 of SEBI ( Listing Obligations and Disclosure Requirements) Regulations, 2015 , we hereby inform you that the meeting of the Board of Directors of the Company was held on July 09, 2025 and the Board has inter-alia approved the following: 1. Fresh approval of the borrowing limit of the Company of Rs. 50.00 Crores in excess of the limit as prescribed under Section 180(1) (c) of the Companies Act, 2013. 2. Creates mortgages /charges on the assets of the Company to secure the borrowings from time to time, within the overall ceiling approved in terms of Section 180(1) (c) of the Companies Act, 2013. 3. Revised the Notice for the forthcoming Annual General Meeting to be held on Thursday, August 21, 2025 at 11:00 A.M., through Video Conferencing ('VC') or Other Audio Visual Means ('OAVM') which includes voting by electronic means. The Board of Directors'' Meeting started at 4.00 P.M. and ended at 4.40 P.M., on the same day. Kindly take the information on record.

pdf

GKB Ophthalmics Ltd.

30 Jun 2025

74.89

2.56%

Company Update

GKB Ophthalmics Ltd - 533212 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) …

BSE India

Pursuant to Regulation 7(2) read with Regulation 6(2) of SEBI( Prohibition of Insider Trading) Regulation, 2015(PIT Regulation, 2015), intimation be and is hereby given that Krishna Gopal Gupta & Sons (HUF), has purchased 3535 equity shares aggregating to Rs. 269921.15/- from 12.06.2025 to 23.06.2025, on market, which is not exceeding the threshold limit as prescribed under Regulation 7(2) of PIT Regulation, 2015. However , as a good Corporate Governance measure, the disclosure required under Regulation 7(2) read with Regulation 6(2) of PIT Regulation, 2015, is enclosed herewith along with the copy of disclosure received from Krishna Gopal Gupta and Sons-HUF. Please acknowledge and take the same on record.

pdf

GKB Ophthalmics Ltd.

27 Jun 2025

74.89

2.56%

SAST

GKB Ophthalmics Ltd - 533212 - Closure of Trading Window

BSE India

Pursuant to SEBI( Prohibition of Insider Trading) Regulation 2015, as amended from time to time , the "Trading Window" for dealing/ trading in the shares of the Company shall remain closed from July 01, 2025, till the completion of 48 hours after the declaration of the financial results of the company, for the first quarter ended June 30, 2025. Accordingly, all the Promoters , Directors and Designated Persons of the Company and their immediate relatives are being intimated to not to enter into any transaction involving trading in shares of the Company, during the period of closure of Trading Window. Further, the date of Board meeting at which the said results will be considered , shall be intimated in due course of time.

pdf

GKB Ophthalmics Ltd.

02 Jun 2025

74.89

2.56%

Company Update

GKB Ophthalmics Ltd - 533212 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Please find attached copies of newspaper cuttings of the extract of statement of audited Standalone and Consolidated Financial Results for the year ended March 31, 2025, published in The Financial Express (Mumbai Edition) and on Pudhari(Marathi) Dated June 01, 2025.

pdf

GKB Ophthalmics Ltd.

30 May 2025

74.89

2.56%

Result

GKB Ophthalmics Ltd - 533212 - GKB- Audited Standalone And Consolidated Financial Results For The Quarter …

BSE India

Please find enclosed the Audited Standalone and Consolidated Results for the quarter and year ended March 31, 2025.

pdf

GKB Ophthalmics Ltd.

30 May 2025

74.89

2.56%

Company Update

GKB Ophthalmics Ltd - 533212 - Compliances-Reg.24(A)-Annual Secretarial Compliance

BSE India

Pursuant to circular no. CIR/CFD/CMDI/27/2019 dated February 08, 2019, issued by the securities and Exchange Board of India, for the purpose of compliance with Regulation 24A of SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015, enclosed please find the Annual Secretarial Complaince Report for the year ended March 31, 2025, issued by Ms. Girija Nagvekar, Practicing Company Secretary and Secretarial Auditor of the Company.

pdf

GKB Ophthalmics Ltd.

30 May 2025

74.89

2.56%

Board Meeting

GKB Ophthalmics Ltd - 533212 - Board Meeting Outcome for Outcome Of The Board Meeting Held …

BSE India

The meeting of the Board of Directors was held on May 30, 2025 which inter-alia approved and took on record the Audited Standalone and Consolidated Financials Results of the Company for the quarter and year ended March 31, 2025. Enclosed please find the Standalone and Consolidated financial results together with the Auditors'' Report. The Board of Directors'' Meeting started at 5:15 P.M. and ended at 6.00 P.M. Kindly take the information on record.

pdf

GKB Ophthalmics Ltd.

14 May 2025

74.89

2.56%

Board Meeting

GKB Ophthalmics Ltd - 533212 - Board Meeting Intimation for Approval Of Audited Standalone And Consolidated …

BSE India

GKB Ophthalmics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve Audited Standalone and Consolidated Financial Results of the company for the quarter and year ended March 31, 2025. The Notice can be accessed at the Company''s Website at www.gkb.net Further,notice is hereby given with reference to the above meeting of the Board of Directors that the Trading Window for dealing with equity shares of the Company, by designated persons, under the SEBI (Prohibition of Insider Trading) Regulation, 2015, had been closed from April 01, 2025, will now re-open after the completion of 48 hours from the date of submission of financials results to the Stock Exchange. This communication has been sent to all the Directors and all the designated employees of the Company.

pdf

Is GKB Ophthalmics Ltd. worth buying?

12 Votes:

Buy 66.67%

Sell 33.33%